Home Overview Press Room Blog Publications For Students about us
Search

CGS Testifies at First US Congressional Hearing on Global Governance of Human Biotech

Genetic Crossroads
July 16th, 2008

On Thursday, June 19 the US House Foreign Affairs Committee Subcommittee on Terrorism, Nonproliferation and Trade, chaired by Rep. Brad Sherman (D-Los Angeles), held a hearing on "Genetics and Other Human Modification Technologies: Sensible International Regulation or a New Kind of Arms Race."

Among those testifying were CGS Executive Director Richard Hayes, who had been asked to address the question, "Is there an emerging international consensus on the proper uses of the new human genetic technologies?" He argued that there is.

Others testifying were Jamie Metzl of The Asia Society; Nigel Cameron of the Center for Policy on Emerging Technologies; and Paul Billings of Signature Genomics Laboratories.

During the proceedings Congressman Sherman noted that "bright red lines" would likely need to be drawn, but that it was not yet clear exactly where. He said he expected to entertain proposals for legislative action.

More:

Richard Hayes: full testimony [PDF]

Summaries of all testimonies

Jamie Metzl: "Brave New World War"


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760